leisure time -WSS

leisure time

author：focus 2025-09-30 22:07:45 - browse：87

David Liu and Jonathan Wosen on the STAT Summit stage. — David Liu (left) with reporter Jonathan Wosen at the 2022 STAT Summit. STAT

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned.

The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with knowledge of the situation. Bluebird had not previously disclosed Bonner’s departure.

Nvelop is the latest entry in a race among top labs and deep-pocketed investors to solve a delivery problem that has stunted efforts to turn CRISPR and other genetic tools into disease-altering medicines. The goal is to develop a cargo system precise enough to deliver CRISPR or other machinery to cells of a researchers’ choosing, particularly tissues that have been hard to reach with previous approaches, like neurons, muscle, and blood stem cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Medicare Advantage 2025 payments will dip, Biden administration says

WSS

Melinda French Gates resigns from Gates Foundation

Hundreds died while taking an arthritis drug, but nobody alerted patients

UnitedHealth financials solid despite Change Healthcare cyberattack

UnitedHealth financials solid despite Change Healthcare cyberattack

Cancer researcher Catriona Jamieson is sending tumors into space

UnitedHealth financials solid despite Change Healthcare cyberattack

focus

leisure time

explore

Psychedelics group wrestles with new pharma identity

Researchers test human milk's ability to repair gut microbiome

Duchenne breakthrough therapy leaves behind pioneering families

Covid silver lining: Unprecedented look at human immune system

Anesthesiologist group: stop taking Ozempic before surgery

Cue Health's Covid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medicare Advantage 2025 payments will dip, Biden administration says

After affirmative action ruling, medical educators look to 'holistic review'

More tobacco lobbyists active in statehouses

hotspot

Study: Black kids more likely to die after surgery than white kids

Overprescribed: High cost isn't America's only drug problem

Medical bills so high, Medicare adding extra digits to claim forms

H5N1 bird flu found in pasteurized milk: what we know

Researchers test human milk's ability to repair gut microbiome

Getting Alzheimer's drug Leqembi to patients can be a challenge

focus

focus

knowledge

focus